You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

CLINICAL TRIALS PROFILE FOR BUPIVACAINE LIPOSOME


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for BUPIVACAINE LIPOSOME

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01507220 ↗ A Health Economic Trial in Adult Patients Undergoing Open Colectomy MA402S23B301 Terminated Registrat-Mapi Phase 4 2012-03-01 This study is designed to compare the standard of care against EXPAREL (bupivacaine liposome extended-release injectable suspension) to determine if total opioid consumption is reduced when using EXPAREL therefore possibly reducing total hospitalization costs.
NCT01507220 ↗ A Health Economic Trial in Adult Patients Undergoing Open Colectomy MA402S23B301 Terminated Pacira Pharmaceuticals, Inc Phase 4 2012-03-01 This study is designed to compare the standard of care against EXPAREL (bupivacaine liposome extended-release injectable suspension) to determine if total opioid consumption is reduced when using EXPAREL therefore possibly reducing total hospitalization costs.
NCT01507233 ↗ A Health Economic Trial in Adult Patients Undergoing Open Colectomy MA402S23B302 Terminated Registrat-Mapi Phase 4 2012-05-01 This study is designed to compare the standard of care against EXPAREL (bupivacaine liposome extended-release injectable suspension) to determine if total opioid consumption is reduced when using EXPAREL, therefore possibly reducing total hospitalization costs.
NCT01507233 ↗ A Health Economic Trial in Adult Patients Undergoing Open Colectomy MA402S23B302 Terminated Pacira Pharmaceuticals, Inc Phase 4 2012-05-01 This study is designed to compare the standard of care against EXPAREL (bupivacaine liposome extended-release injectable suspension) to determine if total opioid consumption is reduced when using EXPAREL, therefore possibly reducing total hospitalization costs.
NCT01507246 ↗ Adult Patients Undergoing Open Colectomy MA402S23B303 Completed Registrat-Mapi Phase 4 2011-12-01 This study is designed to compare the standard of care against EXPAREL(R) to determine if total opioid consumption is reduced when using EXPAREL, therefore possibly reducing total hospitalization costs.
NCT01507246 ↗ Adult Patients Undergoing Open Colectomy MA402S23B303 Completed Pacira Pharmaceuticals, Inc Phase 4 2011-12-01 This study is designed to compare the standard of care against EXPAREL(R) to determine if total opioid consumption is reduced when using EXPAREL, therefore possibly reducing total hospitalization costs.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for BUPIVACAINE LIPOSOME

Condition Name

Condition Name for BUPIVACAINE LIPOSOME
Intervention Trials
Pain, Postoperative 8
Postoperative Pain 5
Total Knee Arthroplasty 4
Opioid Use 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for BUPIVACAINE LIPOSOME
Intervention Trials
Pain, Postoperative 17
Intestinal Obstruction 4
Shoulder Pain 3
Osteoarthritis 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for BUPIVACAINE LIPOSOME

Trials by Country

Trials by Country for BUPIVACAINE LIPOSOME
Location Trials
United States 57
China 2
Belgium 2
Poland 1
Georgia 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for BUPIVACAINE LIPOSOME
Location Trials
New York 9
Florida 7
Ohio 6
New Jersey 3
Texas 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for BUPIVACAINE LIPOSOME

Clinical Trial Phase

Clinical Trial Phase for BUPIVACAINE LIPOSOME
Clinical Trial Phase Trials
Phase 4 32
Phase 3 2
Phase 2/Phase 3 3
[disabled in preview] 7
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for BUPIVACAINE LIPOSOME
Clinical Trial Phase Trials
Completed 17
Recruiting 11
Terminated 9
[disabled in preview] 11
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for BUPIVACAINE LIPOSOME

Sponsor Name

Sponsor Name for BUPIVACAINE LIPOSOME
Sponsor Trials
Pacira Pharmaceuticals, Inc 17
Registrat-Mapi 6
Icahn School of Medicine at Mount Sinai 2
[disabled in preview] 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for BUPIVACAINE LIPOSOME
Sponsor Trials
Other 53
Industry 18
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.